Bumper Offer - Urjas oil Just @ Rs. 1
Olo, a prescription drug, is manufactured in various forms such as Drops. Primarily, it is used for the treatment of Conjunctivitis. Secondary and off-label uses of Olo have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Olo. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Olo side effects, there are can be others also. These have been listed below. These side effects of Olo are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Olo's effect during pregnancy is Moderate and Moderate while nursing. In addition, Olo's effects on the liver, heart and kidney are discussed below in the Olo related warnings section.
The section on Olo contraindications lists all such conditions.
Additionally, Olo may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Olo, it is important to know that it is safe while driving, and is habit-forming.
Olo is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Olo is used -
Mild
Is the use of Olo safe for pregnant women?
Olo may have some side effects during pregnancy. Pregnant women should discontinue the use of Olo, and talk to their doctor, if they notice any discomfort.
Is the use of Olo safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Olo. Immediately discontinue Olo if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Olo on the Kidneys?
Very few cases of side effects of Olo on kidney have been reported.
What is the effect of Olo on the Liver?
Very few cases of side effects of Olo on the liver have been reported.
What is the effect of Olo on the Heart?
Olo is completely safe for the heart.
Olo should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Olo unless your doctor advises you to do so -
Is this Olo habit forming or addictive?
Olo is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Olo will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Olo is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Olo is unable to treat or cure mental disorders.
Interaction between Food and Olo
Due to the absence of research, it is difficult to say how Olo and food will interact.
Interaction between Alcohol and Olo
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Olo.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1398
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pataday™ (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pazeo (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Patanol® (olopatadine hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1398
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pataday™ (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pazeo (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Patanol® (olopatadine hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1398
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pataday™ (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pazeo (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Patanol® (olopatadine hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1398
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pataday™ (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pazeo (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Patanol® (olopatadine hydrochloride)
